Skip to main content
logo
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7210
+0.0079 (1.11%)
At close: Sep 4, 2026, 4:00 PM EDT
0.7300
+0.0090 (1.25%)
After-hours: Sep 4, 2026, 6:54 PM EDT

Daré Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.371.030.012.8110-
Revenue Growth
-10429.36%-99.65%-71.92%--
Cost of Revenue
-1.970.3-21.6430.140.1
Gross Profit
3.330.730.01-18.83-20.14-0.1
Selling, General & Admin
8.928.769.1611.9111.248.35
Research & Development
5.525.5214.31--30.62
Operating Expenses
14.4414.2923.4611.9111.2438.97
Operating Income
-11.11-13.55-23.45-30.74-31.39-39.07
Other Non Operating Income (Expenses)
0.120.15200.780.440
EBT Excluding Unusual Items
-10.99-13.4-3.45-29.96-30.95-39.07
Gain (Loss) on Sale of Assets
---0.6---
Other Unusual Items
----0.4-0.37
Pretax Income
-10.99-13.4-4.05-30.16-30.95-38.7
Net Income
-10.99-13.4-4.05-30.16-30.95-38.7
Net Income to Common
-10.99-13.4-4.05-30.16-30.95-38.7
Net Income Growth
------
Shares Outstanding (Basic)
14118775
Shares Outstanding (Diluted)
14118775
Shares Change
62.78%31.55%16.80%3.23%38.29%103.23%
EPS (Basic)
-0.78-1.20-0.48-4.15-4.39-7.59
EPS (Diluted)
-0.78-1.20-0.48-4.15-4.39-7.59
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.76-10.274.9-39.49-18.15-28.78
Free Cash Flow Per Share
-0.83-0.920.58-5.43-2.58-5.65
Gross Margin
243.91%71.29%100.00%--201.42%-
Operating Margin
-813.38%-1315.51%-239692.20%-1094.77%-313.86%-
Profit Margin
-804.37%-1300.66%-41430.90%-1074.17%-309.48%-
Free Cash Flow Margin
-860.62%-997.01%50086.97%-1406.26%-181.52%-
EBITDA
-8.98-11.92-23.41-30.7-31.36-39.04
D&A For EBITDA
2.131.630.040.040.020.03
EBIT
-11.11-13.55-23.45-30.74-31.39-39.07
Revenue as Reported
1.371.030.012.8110-
SEC Filings: 10-K · 10-Q